Bioanalytical Syst (BASI) Stock Price & Overview

NASDAQ:BASI

Current stock price

16.44
+1.42 (+9.45%)
At close:
15.65
-0.79 (-4.81%)
After Hours:

The current stock price of BASI is 16.44 null. Today BASI is up by 9.45%. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.

BASI Key Statistics

52-Week Range3.05 - 21.08
Current BASI stock price positioned within its 52-week range.
1-Month Range12.5 - 21.08
Current BASI stock price positioned within its 1-month range.
Market Cap
182.994M
P/E
N/A
Fwd P/E
182.67
EPS (TTM)
-0.32
Dividend Yield
N/A

BASI Stock Performance

Today
+9.45%
1 Week
-7.74%
1 Month
+4.51%
3 Months
+92.73%
Longer-term
6 Months +238.97%
1 Year +415.36%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

BASI Stock Chart

Bioanalytical Syst / BASI Daily stock chart

BASI Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BASI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BASI. Both the profitability and financial health of BASI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BASI Earnings

Next Earnings DateN/A
Last Earnings DateN/A

BASI Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next Y40%
Revenue Next YearN/A

BASI Financial Highlights

Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.


Income Statements
Revenue(TTM)65.44M
Net Income(TTM)-3.63M
Industry RankSector Rank
PM (TTM) -5.54%
ROA -5.77%
ROE N/A
Debt/Equity 2.31
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%38.45%
EPS 1Y (TTM)-190.91%
Revenue 1Y (TTM)36.58%

BASI Ownership

Ownership
Inst Owners15.86%
Shares11.13M
Float8.55M
Ins Owners14.77%
Short Float %N/A
Short RatioN/A

About BASI

Company Profile

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.

Company Info

Bioanalytical Syst

2701 KENT AVENUE

WEST LAFAYETTE IN 47906

CEO: Robert W. Leasure Jr.

Phone: 765-463-4527

Bioanalytical Syst / BASI FAQ

Can you describe the business of Bioanalytical Syst?

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.


What is the current price of BASI stock?

The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.


Does Bioanalytical Syst pay dividends?

BASI does not pay a dividend.


What is the ChartMill rating of Bioanalytical Syst stock?

BASI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is BASI stock listed?

BASI stock is listed on the Nasdaq exchange.


Can you provide the ownership details for BASI stock?

You can find the ownership structure of Bioanalytical Syst (BASI) on the Ownership tab.